Bruker Acquires mNGS DISQVER Platform for Pathogenic Microorganisms in Blood

TheDISQVER clinical metagenomics platform is now part of the Bruker portfolio Providing metagenomic next-generation sequencing mNGS analysis of microbes directly from blood samples the platform is availablefor research use only while Bruker is progressing its registration for diagnostic purposes